ES510029A0 - "procedimiento de obtencion de derivados tiolicos de la eritromicina y del ester propionico de la eritromicina". - Google Patents

"procedimiento de obtencion de derivados tiolicos de la eritromicina y del ester propionico de la eritromicina".

Info

Publication number
ES510029A0
ES510029A0 ES510029A ES510029A ES510029A0 ES 510029 A0 ES510029 A0 ES 510029A0 ES 510029 A ES510029 A ES 510029A ES 510029 A ES510029 A ES 510029A ES 510029 A0 ES510029 A0 ES 510029A0
Authority
ES
Spain
Prior art keywords
erythromycin
thyolic
derivatives
procedure
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES510029A
Other languages
English (en)
Other versions
ES8305378A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of ES510029A0 publication Critical patent/ES510029A0/es
Publication of ES8305378A1 publication Critical patent/ES8305378A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ES510029A 1982-01-20 1982-02-02 "procedimiento de obtencion de derivados tiolicos de la eritromicina y del ester propionico de la eritromicina". Expired ES8305378A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8200821A FR2519988B1 (fr) 1982-01-20 1982-01-20 Derives thioliques de l'erythromycine a activite therapeutique, procede de preparation et produits pharmaceutiques dans lesquels ils apparaissent

Publications (2)

Publication Number Publication Date
ES510029A0 true ES510029A0 (es) 1983-05-01
ES8305378A1 ES8305378A1 (es) 1983-05-01

Family

ID=9270148

Family Applications (1)

Application Number Title Priority Date Filing Date
ES510029A Expired ES8305378A1 (es) 1982-01-20 1982-02-02 "procedimiento de obtencion de derivados tiolicos de la eritromicina y del ester propionico de la eritromicina".

Country Status (4)

Country Link
US (1) US4476120A (es)
ES (1) ES8305378A1 (es)
FR (1) FR2519988B1 (es)
IT (1) IT1193039B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1173441B (it) * 1984-03-14 1987-06-24 Edmond Pharma Srl Sali di eritromicina con derivati dell'acido acetico,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US5637616A (en) * 1993-06-18 1997-06-10 Arcturus Pharmaceutical Corporation Method for treating diseases mediated by proteases
CA2164955A1 (en) * 1993-06-18 1995-01-05 Richard J. Sharpe Method for treating hyperkeratosis and diseases mediated by proteases
GB2320431B (en) * 1996-12-20 2000-08-30 Johnson & Johnson Medical Compositions for the treatment of chronic wounds
ATE260665T1 (de) 1998-10-20 2004-03-15 Russinsky Ltd Derivate des erythromycins, des clarithromycins, des roxithromycins oder des azithromycin mit antibiotischer und mucolytischer wirkung
NZ518401A (en) * 1999-10-29 2004-01-30 Nektar Therapeutics Dry powder compositions having improved dispersivity
US6566401B2 (en) * 2001-03-30 2003-05-20 The Board Of Trustees Of The Leland Stanford Junior University N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2653899A (en) * 1952-04-14 1953-09-29 Lilly Co Eli Erythromycin, its salts, and method of preparation
US2743268A (en) * 1952-07-12 1956-04-24 Lilly Co Eli Erythromycin-penicillin
US2830982A (en) * 1955-06-03 1958-04-15 Abbott Lab Water-soluble salt of erythromycin
US3558594A (en) * 1968-09-04 1971-01-26 Abbott Lab Erythromycin aliphatic sulfate
GB1250045A (en) * 1969-01-15 1971-10-20 Pierrel Spa A new water soluble derivative of erythromycin
US3847896A (en) * 1973-04-09 1974-11-12 Upjohn Co Erythromycin-2-thiol esters and process
DK139522C (da) * 1975-04-07 1979-08-20 Thomae Gmbh Dr K Analogifremgangsmaade til fremstilling af 9-iminoalkylamino-erythromyciner eller syreadditionssalte deraf
US4261982A (en) * 1977-11-09 1981-04-14 The Procter & Gamble Company Therapeutic composition
US4264765A (en) * 1980-02-20 1981-04-28 Abbott Laboratories Salts of erythromycin A esters

Also Published As

Publication number Publication date
IT8219409A0 (it) 1982-02-02
FR2519988B1 (fr) 1985-06-14
ES8305378A1 (es) 1983-05-01
US4476120A (en) 1984-10-09
IT1193039B (it) 1988-06-02
FR2519988A1 (fr) 1983-07-22

Similar Documents

Publication Publication Date Title
ES512067A0 (es) "procedimiento para la preparacion de derivados de eter arilfenilico".
ES511955A0 (es) "procedimiento para la preparacion de derivados de cefem".
ES515453A0 (es) "procedimiento para la preparacion de esteres perfluoroalcohilicos".
IT1124875B (it) Mezzi per l'attivazione e la disattivazione di innesti
FI914393A0 (fi) Anordning foer soenderdelning av konkrement i kroppen pao en patient.
ES515375A0 (es) Procedimiento para la preparacion de derivados de 3-piridilo y 2-piracinilo.
ES510677A0 (es) "procedimiento para la preparacion de acidos oxazafosforin-4-tio-alcansulfonicos".
ES513831A0 (es) "procedimiento para la preparacion de esteres carboxilicos de 6-hidroxi-2-benzotiazolsulfonamida".
ES513672A0 (es) "procedimiento para la preparacion de derivados de penem".
ES513846A0 (es) "procedimiento para la preparacion de nuevos derivados de acidos 2-amino-carboxilicos".
ES499299A0 (es) Procedimiento de preparacion de derivados de la trimetoxi- 3,4,5 cinamoilpiperacina
ES510029A0 (es) "procedimiento de obtencion de derivados tiolicos de la eritromicina y del ester propionico de la eritromicina".
SE8204292D0 (sv) Substituerade tiazolo(3,2-a)pyrymidiner och forfarande for framstellning derav
ES513619A0 (es) "procedimiento para la preparacion de derivados de 1-azolil-2-hidroxi-alcano".
ES517428A0 (es) Procedimiento de preparacion de derivados bencilidenicos.
ES509958A0 (es) Procedimiento para la obtencion de derivados de aminoacridin (d) y (l)-n-glicosido.
ES512268A0 (es) "procedimiento de obtencion de acidos alfa-n-pirrolil-derivados".
ES516787A0 (es) "procedimiento para la fabricacion de derivados de 5-aminoisoxazol".
ES491732A0 (es) Procedimiento de preparacion de monohidrato de 1,25-dihidro-xi-colecalciferol
IT7823392A0 (it) 17 beta-idrossi-4-androsten-3-oni e procedimento per la loro preparazione.
ES514844A0 (es) "procedimiento para la preparacion de derivados de 5(6)-fenil-sulfoniloxi-bencimidazol".
BE894245A (fr) Derives d'esters de n-arylsulfinyl-n-phosphonomethylglycinates
ES513956A0 (es) "procedimiento para la carbonilacion de olefinas y esteres organicos".
ES518725A0 (es) Procedimiento de preparacion de nuevos derivados del azabiciclo (3.2.0) heptano.
ES511809A0 (es) "procedimiento de preparacion de derivados de acidos fenoxibenzoicos".